P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis - PubMed (original) (raw)
. 2010 Jun;20(6):1263-73.
doi: 10.1093/cercor/bhp193. Epub 2009 Sep 26.
Affiliations
- PMID: 19783848
- DOI: 10.1093/cercor/bhp193
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis
Susanna Amadio et al. Cereb Cortex. 2010 Jun.
Abstract
Although Multiple Sclerosis (MS) is regarded as a white matter disease, the incidence of demyelination and axonal injury is prominent also in gray matter. In MS, extracellular adenosine triphosphate (ATP) is an important mediator of central nervous system pathology via its ability to cause oligodendrocyte excitotoxicity. We have analyzed the distribution pattern of all ionotropic P2X and metabotropic P2Y receptors for ATP in postmortem samples of the cerebral cortex from healthy human subjects as well as MS patients. We focus particularly on the P2Y(12) subtype that is highly enriched in oligodendrocytes. We correlate the expression of this receptor to the extent of gray matter demyelination and pathological alterations occurring during secondary progressive MS. Using triple immunofluorescence and confocal analysis, we show that in sections of cerebral cortex from postmortem MS brains, the P2Y(12) protein is present in myelin and interlaminar astrocytes but absent from protoplasmic astrocytes residing in the deeper cortical layers, from microglia/macrophages, and from intact demyelinated axons. We report that a decreased P2Y(12) receptor immunoreactivity in proximity to the lesions is directly correlated with the extent of demyelination found in all types of gray matter cortical plaques (I-III) and subcortical white matter. Our study provides further insights into the pathogenetic features of MS and suggests that the loss of purinergic P2Y(12) receptors might be detrimental to tissue integrity.
Similar articles
- Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA. Trapp BD, et al. Lancet Neurol. 2018 Oct;17(10):870-884. doi: 10.1016/S1474-4422(18)30245-X. Epub 2018 Aug 22. Lancet Neurol. 2018. PMID: 30143361 Free PMC article. - Cortical remyelination: a new target for repair therapies in multiple sclerosis.
Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD. Chang A, et al. Ann Neurol. 2012 Dec;72(6):918-26. doi: 10.1002/ana.23693. Epub 2012 Oct 17. Ann Neurol. 2012. PMID: 23076662 Free PMC article. - Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.
Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Gray E, et al. Brain Pathol. 2008 Jan;18(1):86-95. doi: 10.1111/j.1750-3639.2007.00110.x. Epub 2007 Nov 27. Brain Pathol. 2008. PMID: 18042261 Free PMC article. - Grey matter pathology in multiple sclerosis.
Bö L, Geurts JJ, Mörk SJ, van der Valk P. Bö L, et al. Acta Neurol Scand Suppl. 2006;183:48-50. doi: 10.1111/j.1600-0404.2006.00615.x. Acta Neurol Scand Suppl. 2006. PMID: 16637929 Review. - Purinergic receptors in multiple sclerosis pathogenesis.
Domercq M, Zabala A, Matute C. Domercq M, et al. Brain Res Bull. 2019 Sep;151:38-45. doi: 10.1016/j.brainresbull.2018.11.018. Epub 2018 Nov 27. Brain Res Bull. 2019. PMID: 30500565 Review.
Cited by
- Ion Channels as New Attractive Targets to Improve Re-Myelination Processes in the Brain.
Cherchi F, Bulli I, Venturini M, Pugliese AM, Coppi E. Cherchi F, et al. Int J Mol Sci. 2021 Jul 6;22(14):7277. doi: 10.3390/ijms22147277. Int J Mol Sci. 2021. PMID: 34298893 Free PMC article. Review. - Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Lecca D, Ceruti S, Fumagalli M, Abbracchio MP. Lecca D, et al. Purinergic Signal. 2012 Sep;8(3):539-57. doi: 10.1007/s11302-012-9310-y. Epub 2012 Apr 12. Purinergic Signal. 2012. PMID: 22528683 Free PMC article. Review. - Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements.
Zhou Y, Zhang J. Zhou Y, et al. Front Cell Dev Biol. 2023 Jul 26;11:1221890. doi: 10.3389/fcell.2023.1221890. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37564376 Free PMC article. Review. - Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.
Cieślak M, Kukulski F, Komoszyński M. Cieślak M, et al. Purinergic Signal. 2011 Dec;7(4):393-402. doi: 10.1007/s11302-011-9250-y. Epub 2011 Jul 27. Purinergic Signal. 2011. PMID: 21792574 Free PMC article. - Update of P2Y receptor pharmacology: IUPHAR Review 27.
Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kügelgen I, Li B, Miras-Portugal MT, Novak I, Schöneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Müller CE. Jacobson KA, et al. Br J Pharmacol. 2020 Jun;177(11):2413-2433. doi: 10.1111/bph.15005. Epub 2020 Apr 6. Br J Pharmacol. 2020. PMID: 32037507 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical